Ultragenyx Pharmaceutical (RARE)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 214.70 mm | 214.70 mm | 214.70 mm | 214.70 mm | 214.70 mm | 214.70 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 59.85 mm | 48.06 mm | 30.47 mm | 37.14 mm |
| Cash used (since last report) | n/a | n/a | 82.84 mm | 66.53 mm | 42.18 mm | 51.41 mm |
| Cash remaining | n/a | n/a | 131.86 mm | 148.17 mm | 172.52 mm | 163.29 mm |
| Runway (months of cash) | n/a | n/a | 2.2 | 3.1 | 5.7 | 4.4 |
| 13F holders | Current |
|---|---|
| Total holders | 313 |
| Opened positions | 56 |
| Closed positions | 45 |
| Increased positions | 111 |
| Reduced positions | 108 |
| 13F shares | Current |
|---|---|
| Total value | 3.48 tn |
| Total shares | 87.46 mm |
| Total puts | 845.52 k |
| Total calls | 666.46 k |
| Total put/call ratio | 1.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 10.03 mm | $422.17 bn |
| BlackRock | 6.54 mm | $274.99 bn |
| Sands Capital Management | 4.30 mm | $180.82 bn |
| STT State Street | 2.72 mm | $114.54 bn |
| T. Rowe Price | 2.51 mm | $105.70 mm |
| Wellington Management | 2.46 mm | $103.39 bn |
| Clearbridge Advisors | 2.32 mm | $97.70 bn |
| FHI Federated Hermes | 2.05 mm | $86.24 bn |
| RTW Investments | 1.97 mm | $82.79 bn |
| Rock Springs Capital Management | 1.74 mm | $73.19 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Oct 25 | Horn Howard | Common Stock | Sell | Dispose S | No | No | 31.51 | 7,942 | 250.25 k | 98,227 |
| 18 Sep 25 | Theodore Alan Huizenga | Common Stock | Sell | Dispose S | No | No | 29.17 | 64 | 1.87 k | 50,242 |
| 12 Sep 25 | Karah Herdman Parschauer | Common Stock | Sell | Dispose S | No | No | 31.17 | 2,450 | 76.37 k | 73,271 |
| 5 Sep 25 | Theodore Alan Huizenga | Common Stock | Sell | Dispose S | No | No | 31.39 | 84 | 2.64 k | 50,306 |
| 20 Jun 25 | Sanders Corazon | Common Stock | Sell | Dispose S | No | No | 37.39 | 2,405 | 89.92 k | 15,344 |